<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Kraneshares Artificial Intelligence & Technology Etf — News on 6ix</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf</link>
<description>Latest news and press releases for Kraneshares Artificial Intelligence & Technology Etf on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/kraneshares-artificial-intelligence-and-technology-etf" rel="self" type="application/rss+xml" />
<item>
<title>Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co-Scientist for Rare Cancers — 8:30 AM Eastern, April 9, 2026</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/lantern-pharma-invites-investors-analysts-and-shareholders-to-experience-the-future-of-drug-discovery-via-a-live-demo-of-withzetaai-the-worlds-first-multi-agentic-co-scientist-for-rare-cancers-830-am-eastern-april-9-2026-48</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/lantern-pharma-invites-investors-analysts-and-shareholders-to-experience-the-future-of-drug-discovery-via-a-live-demo-of-withzetaai-the-worlds-first-multi-agentic-co-scientist-for-rare-cancers-830-am-eastern-april-9-2026-48</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Briefing to Feature a Live Walkthrough, Demonstration of Key Features, The Market Opportunity & Industry Need, Competitive Positioning, and Platform</description>
</item>
<item>
<title>BrightSpire Capital, Inc. Announces First Quarter 2026 Earnings Release and Conference Call Dates</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/brightspire-capital-inc-announces-first-quarter-2026-earnings-release-and-conference-call-dates-26</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/brightspire-capital-inc-announces-first-quarter-2026-earnings-release-and-conference-call-dates-26</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>NEW YORK--(BUSINESS WIRE)-- BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced it will release first quarter</description>
</item>
<item>
<title>Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-7</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-7</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>ESCONDIDO, CA / ACCESS Newswire / April 2, 2026 / Dalrada Technology Group, Inc. (the "Company" or "Dalrada") (OTCID:DHTI), a leader in advanced climate</description>
</item>
<item>
<title>Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/dr-calvin-choi-founder-of-amtd-idea-reappointed-as-the-chief-president-of-the-hong-kong-island-youth-united-association-8</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/dr-calvin-choi-founder-of-amtd-idea-reappointed-as-the-chief-president-of-the-hong-kong-island-youth-united-association-8</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>PARIS and NEW YORK and LONDON, April 2, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE:</description>
</item>
<item>
<title>RXO Schedules First-Quarter 2026 Earnings and Investor Conference Call for May 7, 2026</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/rxo-schedules-first-quarter-2026-earnings-and-investor-conference-call-for-may-7-2026-28</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/rxo-schedules-first-quarter-2026-earnings-and-investor-conference-call-for-may-7-2026-28</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>CHARLOTTE, N.C.--(BUSINESS WIRE)-- RXO (NYSE: RXO) will issue its first-quarter financial results before the opening of the New York Stock Exchange on</description>
</item>
<item>
<title>Pineapple Financial Deepens Strategic Relationship with Canary Capital</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/pineapple-financial-deepens-strategic-relationship-with-canary-capital-17</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/pineapple-financial-deepens-strategic-relationship-with-canary-capital-17</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Appoints Digital Asset Treasury Advisor, Bringing Institutional Portfolio Construction and Capital Strategy Expertise Toronto, Ontario--(Newsfile Corp. -</description>
</item>
<item>
<title>Valley National Bank Celebrates Opening of Melbourne Branch, Strengthening Central Florida Relationships</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/valley-national-bank-celebrates-opening-of-melbourne-branch-strengthening-central-florida-relationships-26</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/valley-national-bank-celebrates-opening-of-melbourne-branch-strengthening-central-florida-relationships-26</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New location provides relationship-focused banking services for commercial and consumer clients MELBOURNE, Fla.--(BUSINESS WIRE)-- Valley National Bank, a</description>
</item>
<item>
<title>CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-1</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 02, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash</description>
</item>
<item>
<title>Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/zoetis-to-host-webcast-and-conference-call-on-first-quarter-2026-financial-results-25</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/zoetis-to-host-webcast-and-conference-call-on-first-quarter-2026-financial-results-25</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 7, 2026. Chief</description>
</item>
<item>
<title>Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/worksport-announces-cortm-portable-energy-system-is-now-fully-certified-including-key-ul-and-csa-approvals-for-north-american-retail-and-commercial-distribution-13</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/worksport-announces-cortm-portable-energy-system-is-now-fully-certified-including-key-ul-and-csa-approvals-for-north-american-retail-and-commercial-distribution-13</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Final safety and compliance approvals complete; certification package supports broader sales across retail, fleet, distributor, and commercial channels WEST</description>
</item>
<item>
<title>IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/iff-launches-purestrongtm-a-probiotic-made-specifically-for-dogs-28</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/iff-launches-purestrongtm-a-probiotic-made-specifically-for-dogs-28</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients and health & biosciences—is introducing PureStrong™, a</description>
</item>
<item>
<title>Orion to Exhibit at LEDucation 2026</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/orion-to-exhibit-at-leducation-2026-20</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/orion-to-exhibit-at-leducation-2026-20</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>MANITOWOC, Wis., April 02, 2026 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting,</description>
</item>
<item>
<title>Olenox Announces Results of Annual Stockholder Meeting</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/olenox-announces-results-of-annual-stockholder-meeting-18</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/olenox-announces-results-of-annual-stockholder-meeting-18</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>CONROE, TX / ACCESS Newswire / April 2, 2026 / Olenox Industries, Inc. (NASDAQ:OLOX) ("Olenox" or the "Company") is pleased to announce the results of its</description>
</item>
<item>
<title>Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanoxarc-systems-45</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanoxarc-systems-45</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New regional partnership strengthens Nanox’s presence and service support across outpatient imaging settings in Colorado, Wyoming and the western parts of</description>
</item>
<item>
<title>ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-3</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Ukraine operations will be structured for full regulatory compliance to support U.S. defense and Gulf nation adoptionVANCOUVER, British Columbia, April 02,</description>
</item>
<item>
<title>Manhattan Named a Leader in 2026 Gartner® Magic Quadrant™ for Transportation Management Systems</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/manhattan-named-a-leader-in-2026-gartnerr-magic-quadranttm-for-transportation-management-systems-15</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/manhattan-named-a-leader-in-2026-gartnerr-magic-quadranttm-for-transportation-management-systems-15</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>ATLANTA--(BUSINESS WIRE)-- Manhattan Associates Inc. (NASDAQ: MANH), a global leader in supply chain commerce solutions with unmatched AI capabilities,</description>
</item>
<item>
<title>Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to</description>
</item>
<item>
<title>Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>April 2, 2026 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies Biodexa Pharmaceuticals PLC (Nasdaq: BDRX)</description>
</item>
<item>
<title>Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-18</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-18</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has</description>
</item>
<item>
<title>PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine</title>
<link>https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-33</link>
<guid isPermaLink="true">https://6ix.com/company/kraneshares-artificial-intelligence-and-technology-etf/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-33</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Deupirfenidone 825 mg TID monotherapy significantly slowed lung function decline versus placebo at 26 weeks in people with idiopathic pulmonary fibrosis</description>
</item>
</channel>
</rss>